Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126770582 | 12677058 | 2 | F | 20160923 | 20160823 | 20160927 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-53990BI | BOEHRINGER INGELHEIM | 0.00 | F | Y | 75.75000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126770582 | 12677058 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Unknown | 300 MG | 22512 | 150 | MG | BID | |||||||
126770582 | 12677058 | 2 | C | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | 115.2 MG | 0 | .4 | MG | ||||||||
126770582 | 12677058 | 3 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG | 0 | 40 | MG | QD | |||||||
126770582 | 12677058 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG | 0 | 5 | MG | QD | |||||||
126770582 | 12677058 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG | 0 | 20 | MG | QD | |||||||
126770582 | 12677058 | 6 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | Oral | 200 MG | 0 | 50 | MG | Q6H | |||||||
126770582 | 12677058 | 7 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | Oral | 3900 MG | 0 | 650 | MG | ||||||||
126770582 | 12677058 | 8 | C | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | Oral | 25 MCG | 0 | 25 | UG | QD | |||||||
126770582 | 12677058 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG | 0 | 40 | MG | QD | |||||||
126770582 | 12677058 | 10 | C | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | STRENGTH: 25-100MG | 0 | TID | |||||||||
126770582 | 12677058 | 11 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 20 MG | 0 | 20 | MG | QD | |||||||
126770582 | 12677058 | 12 | C | OMEGA-3 ACIDS | OMEGA-3 FATTY ACIDS | 1 | Oral | 2000 MG | 0 | 1000 | MG | BID | |||||||
126770582 | 12677058 | 13 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 200 MG | 0 | 100 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126770582 | 12677058 | 1 | Atrial fibrillation |
126770582 | 12677058 | 2 | Chest pain |
126770582 | 12677058 | 3 | Weight increased |
126770582 | 12677058 | 4 | Product used for unknown indication |
126770582 | 12677058 | 5 | Product used for unknown indication |
126770582 | 12677058 | 6 | Product used for unknown indication |
126770582 | 12677058 | 7 | Product used for unknown indication |
126770582 | 12677058 | 8 | Product used for unknown indication |
126770582 | 12677058 | 9 | Product used for unknown indication |
126770582 | 12677058 | 10 | Product used for unknown indication |
126770582 | 12677058 | 11 | Product used for unknown indication |
126770582 | 12677058 | 12 | Product used for unknown indication |
126770582 | 12677058 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126770582 | 12677058 | OT |
126770582 | 12677058 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126770582 | 12677058 | Colon cancer | |
126770582 | 12677058 | Gastric cancer | |
126770582 | 12677058 | Gastrointestinal haemorrhage | |
126770582 | 12677058 | Haematochezia | |
126770582 | 12677058 | Haemorrhagic anaemia | |
126770582 | 12677058 | Melaena |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |